Redescription of <i>Cearadactylus atrox</i> (Pterosauria, Pterodactyloidea) from the Early Cretaceous Romualdo Formation (Santana Group) of the Araripe Basin, Brazil by Alexander W. A. Kellner (153205)

“…There is no rostral gap, and the expanded rostral end of the premaxillae is larger than the dentary, rather than smaller. <i>Cearadactylus atrox</i> is here considered a valid taxon that can be diagnosed by a dentary groove that bifurcates at the rostral end, orbit and naris in a high position relative to the nasoantorbital fenestra, and a comparatively small number of teeth (32–36 maxillary, 22–26 mandibular), decreasing in size towards the posterior end. …”

Conceptual framework. by Hathairat Kosiyaporn (7180853)

“…This study recommends effective infodemic management and comprehensive public communication, prioritising vulnerable groups such as those with a low level of education and people with chronic conditions. …”

Table_2_[18F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson’s Disease Mouse Model of α-Synucleinopathy.DOCX by Rommani Mondal (10971912)

“…<p>Transgenic mice line M83 that express the A53T mutant α–synuclein protein at six times the level of endogenous mice α–synuclein are a model of α-synucleinopathy found in Parkinson’s disease (PD). …”

Image_2_[18F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson’s Disease Mouse Model of α-Synucleinopathy.TIF by Rommani Mondal (10971912)

“…<p>Transgenic mice line M83 that express the A53T mutant α–synuclein protein at six times the level of endogenous mice α–synuclein are a model of α-synucleinopathy found in Parkinson’s disease (PD). …”

Table_1_[18F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson’s Disease Mouse Model of α-Synucleinopathy.DOCX by Rommani Mondal (10971912)

“…<p>Transgenic mice line M83 that express the A53T mutant α–synuclein protein at six times the level of endogenous mice α–synuclein are a model of α-synucleinopathy found in Parkinson’s disease (PD). …”

Image_3_[18F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson’s Disease Mouse Model of α-Synucleinopathy.TIF by Rommani Mondal (10971912)

“…<p>Transgenic mice line M83 that express the A53T mutant α–synuclein protein at six times the level of endogenous mice α–synuclein are a model of α-synucleinopathy found in Parkinson’s disease (PD). …”

Image_1_[18F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson’s Disease Mouse Model of α-Synucleinopathy.TIF by Rommani Mondal (10971912)

“…<p>Transgenic mice line M83 that express the A53T mutant α–synuclein protein at six times the level of endogenous mice α–synuclein are a model of α-synucleinopathy found in Parkinson’s disease (PD). …”

Effects of antioxidant-rich <i>foods</i> on altitude-induced oxidative stress and inflammation in elite endurance athletes: A randomized controlled trial by Anu Elisa Koivisto (6837080)

“…A similar trend was seen for IL6 (p = 0.062). A larger decrease in micro-CRP was detected in the antioxidant group compared to controls (β: -0.62, p = 0.02). …”

Y-P30 effects on neurotrophin expression. by Janine R. Neumann (6330863)

The 500 bp C-terminal of TE is involved in the stress response <i>in vitro</i>. by Minying Li (4477666)

Effect of 500 bp C-terminal of TE deletion on virulence in the <i>F</i>. <i>monophora</i> infection mice model. by Minying Li (4477666)

Demographic characteristics of participants. by Anna Powell (1295466)

“…Data were analysed thematically.</p><p>Results</p><p>Six themes were identified. <i>Beliefs</i> about vaccine safety, necessity, and efficacy often arose from misinformation, misunderstanding, or negative experience. …”

DataSheet1_Metformin Protects Against Diabetes-Induced Cognitive Dysfunction by Inhibiting Mitochondrial Fission Protein DRP1.PDF by Yan Hu (30839)

“…Inhibition of mitochondrial fission by Mdivi-1 and metformin significantly decreased oxidative stress and prevented cell apoptosis in cultured cells. …”

Estimation of actomyosin active force maintained by tropomyosin and troponin complex under vertical forces in the <i>in vitro</i> motility assay system by Shuya Ishii (4840320)

“…At the same time, we demonstrate that the force on reconstituted thin filaments is approximately 1.5 times larger than that on pure actin filaments. …”

6MWT results. by Imane Salmam (21485704)

“…Additionally, VO₂_peak was decreased in most studies (7/10), falling below 80% of the predicted value, indicating impaired aerobic capacity. …”

Flowchart of selected studies. by Imane Salmam (21485704)

“…Additionally, VO₂_peak was decreased in most studies (7/10), falling below 80% of the predicted value, indicating impaired aerobic capacity. …”

Spirometry results. by Imane Salmam (21485704)

“…Additionally, VO₂_peak was decreased in most studies (7/10), falling below 80% of the predicted value, indicating impaired aerobic capacity. …”

Detailed characteristics of included studies. by Imane Salmam (21485704)

“…Additionally, VO₂_peak was decreased in most studies (7/10), falling below 80% of the predicted value, indicating impaired aerobic capacity. …”

Risk of bias assessment of included studies. by Imane Salmam (21485704)

“…Additionally, VO₂_peak was decreased in most studies (7/10), falling below 80% of the predicted value, indicating impaired aerobic capacity. …”

VO_2peak results. by Imane Salmam (21485704)

“…Additionally, VO₂_peak was decreased in most studies (7/10), falling below 80% of the predicted value, indicating impaired aerobic capacity. …”